GeneSYS ID, Inc.

GNID

US37186P1021

Electronic Equipment & Parts

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2018	GeneSYS ID, Inc. cancelled the transaction announced on October 7, 2015	CI
2017	GeneSYS ID, Inc. Announces Board Changes	CI

RX Safes, Inc. Appoints Mark Basile to Serve as a Member of the Board of Directors

September 25, 2015 at 05:19 pm

On September 18, 2015, RX Safes, Inc.'s Board of Directors appointed Mr. Mark Basile to serve as a member of the Board of Directors. Mr. Basile is the principal of the Basile Law Firm and has been practicing at that firm from 1988 to the present. From 2009 to the present, he is the CEO of Axius Consulting Group Inc. From 2012 to 2014, he was the CEO of Axius Entertainment Group.

Latest news about GeneSYS ID, Inc.

GeneSYS ID, Inc. cancelled the transaction announced on October 7, 2015	18-10-06	CI
GeneSYS ID, Inc. Announces Board Changes	17-01-11	CI
GeneSYS ID, Inc. Names Richard Iler as Secretary	16-11-04	CI
GeneSYS ID, Inc. Announces Management Changes	16-10-07	CI
Rx Safes, Inc. will Change its Ticker to GNID from RXSF	16-08-01	CI
Rx Safes, Inc. (OTCPK: RXSF) acquired My TOUCH-ID LLC from Glenn McGinnis and Scott McGinnis for $0.23 million.	16-07-12	CI
Rx Safes, Inc. Announces Executive Changes	16-05-24	CI
Rx Safes Seeks Acquisitions	16-05-24	CI
Rx Safes, Inc. Receives Orders from U.S. Home Builders Consultants, Inc	16-04-26	CI
Rx Safes, Inc. Announces Availability of Rx SafeEHR	16-02-04	CI
Rx Safes, Inc. Announces Executive Appointments	16-02-02	CI
Rx Safes Inc Announces New Patent License Agreement	16-01-27	CI
Rx Seeks Acquisitions	16-01-04	CI
Rx Safes, Inc. will Change its Ticker to RXSF from RXSF.D	15-12-11	CI
Rx Safes, Inc. will Change its Ticker to RXSF.D from RXSF	15-11-12	CI
Rx Safes, Inc. announced that it has received $0.05 million in funding from Kodiak Capital Group LLC.	15-10-06	CI
GeneSYS ID, Inc. announced that it expects to receive $1 million in funding from Kodiak Capital Group LLC	15-10-06	CI
Rx Safes, Inc. Forms Partnership with Mika Medical and Mk Global	15-10-06	CI
Rx Safes, Inc. announced that it has received $0.06 million in funding from Auctus Private Equity Management, Inc.	15-10-05	CI
RX Safes, Inc. Appoints Mark Basile to Serve as a Member of the Board of Directors	15-09-25	CI
Rx Safes, Inc. Appoints William Koch to Serve as Member of the Board of Directors	15-06-25	CI
Rx Safes, Inc. cancelled the transaction announced on February 25, 2015	15-06-18	CI
Rx Safes, Inc. announced that it has received $0.08 million in funding from Auctus Private Equity Management, Inc.	15-06-15	CI
GeneSYS ID, Inc. announced that it has received $0.055 million in funding	15-06-09	CI
Rx Safes, Inc. announced that it expects to receive $0.6 million in funding.	15-05-27	CI

Chart GeneSYS ID, Inc.

Duration

Period

More charts

Company Profile

GeneSYS ID, Inc., formerly RX Safes, Inc., offers various secure fingerprint products and solutions for both the professional and consumer healthcare markets. The Company develops, designs, manufactures and sells finger print activated medication safes and other healthcare storage equipment. It offers autonomous fingerprint medical security solutions for controlled substances. Its products and technology address the economic and social impacts of drug diversion, unauthorized access to medications, prescription drug abuse and poor medication adherence. The Company offers its fingerprint interface as a solution for customers to license and integrate into their own products; jointly develops products with original equipment manufacturer partners to deliver security and accountability to their existing product offerings, and offers customized end user add-on solutions for healthcare facilities, among others. Its product pipeline includes Rx DrugSAFE Pro, Rx DrugSAFE IC and others.

Sector

Electronic Equipment & Parts

More about the company

Sector Biometric Products

	1st Jan change	Capi.
GENESYS ID, INC.	-.--%	19
ORBBEC INC.	-27.70%	1.5B
PAPILON SAVUNMA TEKNOLOJI VE TICARET	+130.65%	131M
SUPREMA INC.	+18.47%	123M
NEXT BIOMETRICS GROUP ASA	+14.93%	81.26M

Biometric Products

GeneSYS ID, Inc.

Equities

GNID

US37186P1021

Electronic Equipment & Parts

RX Safes, Inc. Appoints Mark Basile to Serve as a Member of the Board of Directors

Latest news about GeneSYS ID, Inc.

Chart GeneSYS ID, Inc.

Company Profile

Sector Biometric Products